Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TVRD
$0.99
-2.95%
TVRD
· Tvardi Therapeutics, Inc.
$0.99
-0.03 (-2.95%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.54M
Shares
13.34M
Volume · Oct 22
55.4K
Avg daily vol (3M)
235.84K
All webcasts
Earnings call · FY2021 Q3
Tvardi Therapeutics, Inc. (TVRD) Q3 2021 Earnings Call
Revenue
$20.27M
+118.8% YoY
Diluted EPS
-$0.72
Net income
-$1.01M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 8, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 8, 2021 · complete as-filed document